Germany Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Germany Legal Cannabis Market Growth & Trends
The Germany legal cannabis market size is expected to reach USD 85.6 million by 2030, growing a CAGR of 14.9% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.
Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.
In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.
The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.
Germany Legal Cannabis Market Report Highlights
Germany Legal Cannabis Market Growth & Trends
The Germany legal cannabis market size is expected to reach USD 85.6 million by 2030, growing a CAGR of 14.9% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.
Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.
In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.
The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.
Germany Legal Cannabis Market Report Highlights
- By source, the hemp segment accounted for the largest revenue share in 2023 due to rising demand for hemp-derived CBD oil and its health benefits. Furthermore, food manufacturing processes use hemp seeds and oil, which propels market growth.
- By derivatives,the CBD segment dominated the market with the largest revenue share in 2023, owing to the growing acceptance of CBD and its use in treating various chronic conditions.
- By end-use, the industrial-use segment held the largest market share in 2023 owing to the growing demand for hemp products, including fiber, seed, stalks, hurds, and oils for various industries, such as food & beverage, personal care, and animal care.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. End-use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End-use outlook
2.3. Competitive Landscape Snapshot
CHAPTER 3. GERMANY LEGAL CANNABIS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
CHAPTER 4. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hemp oil
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Marijuana
4.5.1. Market estimates and forecasts, 2018 to 2030, (USD Million)
4.5.2. Flower
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY DERIVATIVES, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. THC
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. End-use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Industrial Use
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Medical Use
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Depression and Anxiety
6.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. Arthritis
6.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.5. Post-Traumatic Stress Disorder (PTSD)
6.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.6. Cancer
6.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.7. Migraines
6.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.8. Epilepsy
6.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.9. Alzheimer’s
6.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.11. Amyotrophic Lateral Sclerosis
6.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.12. Tourette’s
6.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.13. Diabetes
6.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.14. Parkinson's
6.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.15. Glaucoma
6.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.16. Others
6.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Recreational Use
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company Categorization
7.3. Company Market Position Analysis
7.4. Company Profiles
7.4.1. The Cronos Group
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Organigram Holding, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Tilray Brands, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Canopy Growth Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Aurora Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. SynBiotic
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Cansativa GmbH
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. DEMECAN
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Four 20 Pharma
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Avextra Pharma GmbH
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. End-use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End-use outlook
2.3. Competitive Landscape Snapshot
CHAPTER 3. GERMANY LEGAL CANNABIS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
CHAPTER 4. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hemp oil
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Marijuana
4.5.1. Market estimates and forecasts, 2018 to 2030, (USD Million)
4.5.2. Flower
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY DERIVATIVES, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. THC
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. GERMANY LEGAL CANNABIS MARKET SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. End-use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Industrial Use
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Medical Use
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Depression and Anxiety
6.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. Arthritis
6.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.5. Post-Traumatic Stress Disorder (PTSD)
6.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.6. Cancer
6.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.7. Migraines
6.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.8. Epilepsy
6.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.9. Alzheimer’s
6.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.11. Amyotrophic Lateral Sclerosis
6.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.12. Tourette’s
6.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.13. Diabetes
6.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.14. Parkinson's
6.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.15. Glaucoma
6.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.16. Others
6.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Recreational Use
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company Categorization
7.3. Company Market Position Analysis
7.4. Company Profiles
7.4.1. The Cronos Group
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Organigram Holding, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Tilray Brands, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Canopy Growth Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Aurora Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. SynBiotic
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Cansativa GmbH
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. DEMECAN
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Four 20 Pharma
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Avextra Pharma GmbH
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Germany legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Germany legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Germany legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Germany legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Germany legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Germany legal cannabis market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 Germany legal cannabis market: market outlook
Fig. 9 Germany legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Germany legal cannabis market driver impact
Fig. 14 Germany legal cannabis market restraint impact
Fig. 15 Germany legal cannabis market strategic initiatives analysis
Fig. 16 Germany legal cannabis market: Source movement analysis
Fig. 17 Germany legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Germany legal cannabis market: Derivatives movement analysis
Fig. 25 Germany legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Germany legal cannabis market: End-use movement analysis
Fig. 30 Germany legal cannabis market: End-use outlook and key takeaways
Fig. 31 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 32 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 33 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 34 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 35 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 36 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 37 Cancer market estimates and forecasts, 2018 - 2030
Fig. 38 Migraines market estimates and forecasts, 2018 - 2030
Fig. 39 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 40 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 41 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 42 AIDS market estimates and forecasts, 2018 - 2030
Fig. 43 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 44 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 47 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 50 Key company categorization
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 Germany legal cannabis market: market outlook
Fig. 9 Germany legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Germany legal cannabis market driver impact
Fig. 14 Germany legal cannabis market restraint impact
Fig. 15 Germany legal cannabis market strategic initiatives analysis
Fig. 16 Germany legal cannabis market: Source movement analysis
Fig. 17 Germany legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Germany legal cannabis market: Derivatives movement analysis
Fig. 25 Germany legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Germany legal cannabis market: End-use movement analysis
Fig. 30 Germany legal cannabis market: End-use outlook and key takeaways
Fig. 31 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 32 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 33 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 34 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 35 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 36 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 37 Cancer market estimates and forecasts, 2018 - 2030
Fig. 38 Migraines market estimates and forecasts, 2018 - 2030
Fig. 39 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 40 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 41 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 42 AIDS market estimates and forecasts, 2018 - 2030
Fig. 43 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 44 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 47 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 50 Key company categorization
